Back to Search
PHILIP ROSENFELD, M.D.
M.D.
Otolaryngology Physician
NPI: 1811938921Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study.
PMID 18036873·Am J Ophthalmol·2007
3-trial
Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
PMID 16581423·Ophthalmology·2006
3-trial
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
PMID 15885778·Ophthalmology·2005
3-trial
Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
PMID 15350329·Ophthalmology·2004
5-case
Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
PMID 19417570·Curr Opin Ophthalmol·2009
6-review
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
PMID 19381089·Curr Opin Ophthalmol·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1245 HIGHLAND AVE, SUITE 502
ABINGTON, PA 19001 - Phone
- (215) 886-1482
Quick Facts
- NPI
- 1811938921
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile